|
|
Volumn 480, Issue 7375, 2011, Pages 16-17
|
|
Blockbuster drug bows out
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIDIABETIC AGENT;
ANTILIPEMIC AGENT;
ATORVASTATIN;
DALCETRIPIB;
GENERIC DRUG;
UNCLASSIFIED DRUG;
DIABETES;
DRUG DEVELOPMENT;
FAT;
GROWTH;
MARKET SYSTEM;
PHARMACEUTICAL INDUSTRY;
PIPELINE;
RISK FACTOR;
ALZHEIMER DISEASE;
ARTICLE;
DIABETES MELLITUS;
DRUG APPROVAL;
DRUG EFFICACY;
DRUG INDUSTRY;
DRUG MARKETING;
DRUG TARGETING;
ECONOMIC DEVELOPMENT;
INVESTMENT;
PATENT;
PRIORITY JOURNAL;
DRUG INDUSTRY;
DRUGS, GENERIC;
HEPTANOIC ACIDS;
PATENTS AS TOPIC;
PYRROLES;
|
|
EID: 82555195580
PISSN: 00280836
EISSN: 14764687
Source Type: Journal
DOI: 10.1038/480016a Document Type: Article |
|
Times cited : (9)
|
|
References (0)
|
